Figures & data
Table 1. Studies on cardiac surgical approach in patients with carcinoid heart disease.
De Rosa R, Schranz D, Zeiher AM, et al. Again, two melodies in concert: transcatheter double valve replacement in Hedinger syndrome. Ann Thorac Surg. 2017;104(1):e61–e63. Florczak E, Pęczkowska M, Konka M, et al. A 51-year-old patient with carcinoid heart disease and severe tricuspid regurgitation. Kardiol Pol. 2017;75(2):183. Bulur S, Hsiung MC, Nanda NC, et al. Incremental value of live/real time three-dimensional transthoracic echocardiography over the two-dimensional technique in assessing carcinoid heart disease involving the aortic valve. Echocardiography. 2016;33(11):1741–1744. Loyalka P, Schechter M, Nascimbene A, et al. Transcatheter pulmonary valve replacement in a carcinoid heart. Tex Heart Inst J. 2016;43(4):341–344. Jahagirdar V, Kamal A, Steeds R, et al. Metastatic small bowel neuroendocrine tumour with bilateral carcinoid heart disease. BMJ Case Rep. 2016;2016:pii: bcr2015213693. Tsugu T, Iwanaga S, Murata M, et al. Bioprosthetic tricuspid valve replacement in carcinoid heart disease from primary ovarian carcinoid tumour. J Med Ultrasonics. 2015;42(3):401–403. Khan JN, Doshi SN, Rooney SJ, et al. Transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration in carcinoid heart disease. Eur Heart J Cardiovasc Imaging. 2016;17(1):114. Proesmans S, Van Fraeyenhove F, Dossche K, et al. Carcinoid heart disease: a remarkable recovery. Acta Clin Belg. 2015;70(6):453–456. Conradi L, Schaefer A, Mueller GC, et al. Carcinoid heart valve disease: transcatheter pulmonary valve-in-valve implantation in failing biological xenografts. J Heart Valve Dis. 2015;24(1):110–114. Laule M, Pschowski R, Pape UF, et al. Staged catheter-based valve treatment of severe carcinoid heart disease. Neuroendocrinology. 2016;103(3-4):259–262. Heidecker B, Moore P, Bergsland EK, et al. Transcatheter pulmonic valve replacement in carcinoid heart disease. Eur Heart J Cardiovasc Imaging. 2015;16(9):1046. Schaefer A, Sill B, Schoenebeck J, et al. Failing stentless bioprostheses in patients with carcinoid heart valve disease. J Cardiothorac Surg. 2015;10(1):41. Paredes A, Valdebenito M, Gabrielli L, et al. Tricuspid and pulmonary valve involvement in carcinoid syndrome. Report of two cases. Rev Med Chile. 2014;142(5):662–666. Anselmi A, Corbineau H, Boulmier D, et al. Early diffuse coronary artery spasm after heart valve surgery in the carcinoid syndrome. J Card Surg. 2013;28(4):402–403. Pêgo-Fernandes PM, Laurino AM, Ferronato Dde S, et al. Double valve replacement due to dysfunction secondary to carcinoid tumour. Arq Bras Cardiol. 2013;100(3):e32–4. Hastie MJ, Souh J, Ju A, et al. Echo rounds: undiagnosed severe pulmonic regurgitation in a carcinoid patient for tricuspid valve replacement and patent foramen ovale closure. Anesth Analg. 2013;116(2):300–302. Carrilho-Ferreira P, Silva D, Almeida AG, et al. Carcinoid heart disease: outcome after balloon pulmonary valvuloplasty. Can J Cardiol. 2013;29(6):751. Bhattacharyya S, Raja SG, Toumpanakis C, et al. Outcomes, risks and complications of cardiac surgery for carcinoid heart disease. Eur J Cardiothorac Surg. 2011;40(1):168–172. Komoda S, Komoda T, Pavel ME, et al. Cardiac surgery for carcinoid heart disease in 12 cases. Gen Thorac Cardiovasc Surg. 2011;59(12):780–785. Takahashi H, Okada K, Asano M, et al. Bioprosthetic pulmonary and tricuspid valve replacement in carcinoid heart disease from ovarian primary cancer. Circ J. 2009;73(8):1554–1556. Dworakowska D, Gueorguiev M, Laji K, et al. Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid – a case report. Endokrynol Pol. 2008;59(4):342–347. Voigt PG, Braun J, Teng OY, et al. Double bioprosthetic valve replacement in right-sided carcinoid heart disease. Ann Thorac Surg. 2005;79(6):2147–2149. Warner RR. Carcinoid case presentation and discussion: the American perspective. Endocr Relat Cancer. 2003;10:489–496. Brunaud L, Antunes L, Sebbag H, et al. Ovarian strumal carcinoid tumour responsible for carcinoid heart disease. Eur J Obstet Gynecol Reprod Biol. 2001;98(1):124–126. Robiolio PA, Rigolin VH, Harrison JK, et al. Predictors of outcome of tricuspid valve replacement in carcinoid heart disease. Am J Cardiol. 1995;75(7):485–488. Ohri SK, Schofield JB, Hodgson H, et al. Carcinoid heart disease: early failure of an allograft valve replacement. Ann Thorac Surg. 1994;58(4):1161–1163. Lundin L, Hansson HE, Landelius J, et al. Surgical treatment of carcinoid heart disease. J Thorac Cardiovasc Surg. 1990;100(4):552–561. DiSesa VJ, Mills RM, Jr, Collins JJ, Jr. Surgical management of carcinoid heart disease. Chest. 1985;88(5):789–791. Forman MB, Byrd BF, III, Oates JA, et al. Two-dimensional echocardiography in the diagnosis of carcinoid heart disease. Am Heart J. 1984;107(3):492–496. Gutierrez FR, McKnight RC, Jaffe AS, et al. Double porcine valve replacement in carcinoid heart disease. Chest. 1982;81(1):101–103. Schoen FJ, Hausner RJ, Howell JF, et al. Porcine heterograft valve replacement in carcinoid heart disease. J Thorac Cardiovasc Surg. 1981;81(1):100–105. Sworn MJ, Edlin GP, McGill DA, et al. Tricuspid valve replacement in carcinoid syndrome due to ovarian primary. Br Med J. 1980;280(6207):85–86. Okada RD, Ewy GA, Copeland JG. Echocardiography and surgery in tricuspid and pulmonary valve stenosis due to carcinoid-syndrome. Cardiovasc Med. 1979;4:871–881. McGuire MR, Pugh DM, Dunn MI. Carcinoid heart disease. Restrictive cardiomyopathy as a late complication. J Kans Med Soc. 1978;79(12):661–662.